Drug Shortage Report for RECOMBIVAX HB

Last updated on 2022-12-02 History
Report ID 175542
Drug Identification Number 02243676
Brand name RECOMBIVAX HB
Common or Proper name (hepatitis B vaccine [recombinant])
Company Name MERCK CANADA INC
Market Status MARKETED
Active Ingredient(s) HEPATITIS B SURFACE ANTIGEN
Strength(s) 10MCG
Dosage form(s) SUSPENSION SOLUTION
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 10MCG/1ML 1DOSE VIAL
ATC code J07BC
ATC description VIRAL VACCINES
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-12-02
Actual start date 2022-12-01
Estimated end date 2023-03-10
Actual end date
Shortage status Actual shortage
Updated date 2022-12-02
Company comments Remaining doses are reserved for the public immunization program.
Health Canada comments
Tier 3 Status No
Contact Address 16750 ROUTE TRANSCANADIENNE
KIRKLAND, QUEBEC
CANADA H9H 4M7
Company contact information 1-800-567-2594 medinfocanada@merck.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v11 2022-12-02 English Compare
v10 2022-12-01 French Compare
v9 2022-12-01 English Compare
v8 2022-11-28 French Compare
v7 2022-11-28 English Compare
v6 2022-11-28 French Compare
v5 2022-11-28 English Compare
v4 2022-11-25 English Compare
v3 2022-11-24 French Compare
v2 2022-11-24 English Compare
v1 2022-11-24 English Compare

Showing 1 to 11 of 11